$VTGN 👀 July 21st 🔹 Interesting potential catalyst many may be overlooking. 🔹 Vistagen announced on April 22 that the FDA issued a "Study May Proceed" letter

$VTGN 👀 July 21st 🔹 Interesting potential catalyst many may be overlooking. 🔹 Vistagen announced on April 22 that the FDA issued a "Study May Proceed" letter for the IND supporting Refisolone (PH80), allowing clinical development to move forward. 🔹 Vistagen previously entered into an Exclusive N…